Dual time point [18F]Flurodeoxyglucose (FDG) Positron Emission Tomography (PET)/Computed Tomography (CT) with water gastric distension in differentiation between malignant and benign gastric lesions

被引:1
|
作者
Farghaly, Hussein [1 ,2 ]
Alshareef, Mohamed [2 ]
Alqarni, Abdullah [2 ]
Sayed, Mohamed [1 ]
Nasr, Hatem [2 ,3 ]
机构
[1] Assiut Univ, Fac Med, Dept Oncol & Nucl Med, Assiut, Egypt
[2] Prince Sultan Mil Med City, Dept Radiol, Riyadh, Saudi Arabia
[3] Cairo Univ, Fac Med, Dept Oncol & Nucl Med, Cairo, Egypt
关键词
18F]Flurodeoxyglucose positron emission tomography/Computed tomography (F-18 FDG PET/CT); Dual time point imaging; Gastric malignancy; Water gastric distension; F-18-FDG PET; ORAL CONTRAST; FOLLOW-UP; CANCER; DIAGNOSIS; STOMACH; PITFALLS; EXPRESSION; CARCINOMA; TUMOR;
D O I
10.1016/j.ejro.2020.100268
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objectives: To assess diagnostic accuracy and added value of dual time point F-18-FDG PET/CT after gastric distention using oral water in differentiating malignant from benign gastric lesions. Methods: Patients (n = 30, 19 males, mean age 58.6 +/- 16.4 years). All patients are known or suspected oncology patients. All patients underwent whole body F-18-FDG PET/CT scan and 2 h delayed PET/CT abdominal images following oral water gastric distension. The best cut off values for early SUVmax (SUVmax1), delayed SUVmax (SUVmax2) and SUVmax2-SUVmax1 (Delta SUVmax) to differentiate benign from malignant lesions were set based on ROC analysis. Data analyzed included in addition; age, sex and F-18-FDG uptake pattern in delayed images. Suspicious gastric lesions were correlated with biopsy in 18 patients (60 %) and with clinical and follow-up imaging (F-18-FDG PET/CT, CT or MRI) in 12 patients (40 %). Unpaired t-test was used to compare the mean deference in continuous variables between patients with gastric malignancy and those with benign gastric lesions. Fisher's exact test was used to analyze categorical variables. Logistic regression analysis was performed to identify the most powerful factors to predict malignant lesions. Results: Fifteen patients (50 %) had confirmed malignant gastric lesions. Patients with confirmed gastric malignancy were older (65 +/- 13 vs 52 +/- 17; p = 0.023) and had significantly higher mean Delta SUVmax (1.29 +/- 1.76 vs 0.89 +/- 1.59; p = 0.003). The mean SUVmax1 (6.99 +/- 6.66 vs 5.31 +/- 2.53; p = 0.367) and SUVmax2 (8.29 +/- 7.41 vs 4.44 +/- 3.34; p = 0.077) although both higher in patients with malignant lesions, they did not reach statistical significance. Sensitivity, specificity, PPV, NPV, and accuracy to detect malignant gastric lesions were highest for lesions with localized uptake pattern in delayed images post water oral contrast as well as for lesions with Delta SUVmax>0. Regression analysis revealed both variables as independent predictors for malignant lesions with odd ratios of 22.9 and 9.5 respectively and final model Chi-Square of 19.9 (p < 0.0001). The model correctly identified 12/15 (80 %) malignant lesions and 13/15 (86.7 %) benign lesions with 2 false positives confirmed as chronic active gastritis with helicobacter pylori and 3 false negatives including 1 signet ring gastric cancer and 1 low grade gastrointestinal stromal tumor (GIST), both with poor 18 F-FDG uptake. Conclusion: Localized uptake pattern in delayed PET/CT images following gastric distention with oral water contrast as well as Delta SUVmax>0 are powerful independent variables to identify malignant gastric lesions with fairly high sensitivity and reasonable accuracy. Malignancies with inherently low F-18-FDG avidity are the main cause of false negatives while active gastritis is the main cause of false positives.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Differentiation of malignant from benign heart and pericardial lesions using positron emission tomography and computed tomography
    Dan Shao
    Shu-Xia Wang
    Chang-Hong Liang
    Qiang Gao
    Journal of Nuclear Cardiology, 2011, 18 : 668 - 677
  • [32] The performance of dual time point 18F FDG PET for differentiating malignant and benign processes
    Su, Minggang
    Fan, Qiuping
    Fan, Chenzhong
    Tian, Ye
    Li, Fanglan
    Li, Lin
    Kuang, Anren
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [33] [18F]FDG positron emission tomography/computed tomography and multidetector computed tomography roles in thymic lesion treatment planning
    Travaini, Laura L.
    Petralia, Giuseppe
    Trifiro, Giuseppe
    Ravasi, Laura
    Galetta, Domenico
    Carbone, Giuseppe
    Falcini, Fabio
    Spaggiari, Lorenzo
    Bellomi, Massimo
    Paganelli, Giovanni
    LUNG CANCER, 2008, 61 (03) : 362 - 368
  • [34] The value of dual-time point 18F-FDG PET imaging for the differentiation between pulmonary malignant and benign lesions
    Wang, Yuetao
    Liu, Defeng
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [35] THE PROGNOSTIC VALUE OF PRE-TREATMENT DUAL TIME POINT F-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY (FDG PET) WITH COMPUTED TOMOGRAPHY (CT) IN PATIENTS WITH CARCINOMA OF THE UTERINE CERVIX
    Hwang, D.
    Rao, A.
    Wegner, E.
    Shon, I. Ho
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 39 - 40
  • [36] 18F-fiuorodeoxyglucose positron emission tomography/computed tomography findings of gastric lymphoma: Comparisons with gastric cancer
    Wu, Jiang
    Zhu, Hong
    Li, Kai
    Wang, Xin-Gang
    Gui, Yi
    Lu, Guang-Ming
    ONCOLOGY LETTERS, 2014, 8 (04) : 1757 - 1764
  • [37] Comparison of fluorodeoxyglucose-positron emission tomography (FDG-PET) and computerized tomography (CT) in the differentiation of benign and malignant pancreatic disease
    Slavin, A
    Lowe, VJ
    Burton, FR
    Fletcher, JW
    GASTROENTEROLOGY, 1999, 116 (04) : A1114 - A1114
  • [38] [18F]Fluoride Positron-Emission Tomography (PET) and [18F]FDG PET for Assessment of Osteomyelitis of the Jaw in Comparison to Computed Tomography (CT) and Magnetic Resonance Imaging (MRI): A Prospective PET/CT and PET/MRI Pilot Study
    Reinert, Christian Philipp
    Pfannenberg, Christina
    Dittmann, Helmut
    Gueckel, Brigitte
    la Fougere, Christian
    Nikolaou, Konstantin
    Hoefert, Sebastian
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (14)
  • [39] The value of vesicant 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) in gastric malignancies
    Tian, JH
    Chen, L
    Wei, B
    Shao, MZ
    Ding, Y
    Yin, DY
    Yao, SL
    NUCLEAR MEDICINE COMMUNICATIONS, 2004, 25 (08) : 825 - 831
  • [40] Role of [18F]FDG PET/CT for distinguishing benign and malignant lesions of the pancreas
    Orsini, F.
    Volterrani, D.
    Giorgetti, A.
    Guidoccio, F.
    Grosso, M.
    Mariani, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S468 - S469